A physiological pharmacokinetic model describing the disposition of lycopene in healthy men

Journal of Lipid Research

Volumn 44, Issue 10, 2003, Pages 1927-1939

  Diwadkar Navsariwala, Veda ^a   Novotny, Janet A ^b   Gustin, David M ^c   Sosman, Jeffery A ^d   Rodvold, Keith A ^a   Crowell, James A ^e   Stacewicz Sapuntzakis, Maria ^a   Bowen, Phyllis E ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Carotenoids; Human study; Lycopene disposition; Physiological model; Tissue distribution; WinSAAM

Indexed keywords

CAROTENOID; CHYLOMICRON; LIPOPROTEIN; LYCOPENE; VITAMIN;

ARTICLE; BEVERAGE; CANCER CONTROL; CANCER PREVENTION; DOSE RESPONSE; DRUG ABSORPTION; DRUG DISPOSITION; DRUG FORMULATION; DRUG METABOLISM; DRUG SAFETY; GASTROINTESTINAL TRACT; HEPATOMEGALY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTESTINE CELL; LIVER; MALE; MODEL; NORMAL HUMAN; PRIORITY JOURNAL; SIDE EFFECT; SKIN DISCOLORATION; VITAMIN BLOOD LEVEL;

ADULT; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; BEVERAGES; CAROTENOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIPIDS; LIVER; LYCOPERSICON ESCULENTUM; MALE; MIDDLE AGED; PLANT OILS; TISSUE DISTRIBUTION; VITAMINS;

EID: 0242353811     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300130-JLR200     Document Type: Article

References (48)

1. Giovannucci, E., A. Ascherio, E. B. Rimm, M. J. Stampfer, G. A. Colditz, and W. C. Willette. 1995. Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl. Cancer Inst. 87: 1767-1776.
2. Mascio, P. D., S. Kaiser, and H. Sies. 1989. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys. 274: 532-538.
3. Ascherio, A., M. J. Stampfer, G. A. Colditz, E. B. Rimm, L. Litin, and W. C. Willette. 1992. Correlations of vitamin A and E intakes with the plasma concentrations of carotenoids and tocopherols among American men and women. J. Nutr. 122: 1792-1801.
4. Kaplan, L. A., J. M. Lau, and E. A. Stein. 1990. Carotenoid composition, concentrations, and relationships in various human organs. Clin. Physiol. Biochem. 8: 1-10.
5. Schmitz, H. H., C. L. Poor, R. B. Wellman, and J. W. Erdman. 1991. Concentration of selected carotenoids and vitamin A in human liver, kidney and lung tissue. J. Nutr. 121: 1613-1621.
6. Stahl, W., W. Schwarz, A. R. Sundquist, and H. Sies. 1992. Cis-trans isomers of lycopene and β-carotene in human serum and tissues. Arch. Biochem. Biophys. 294: 173-177.
7. Clinton, S. K., C. Emenhiser, S.J. Schwartz, D. G. Bostwick, A. W. Williams, B. J. Moore, and J. W. Erdman. 1996. Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol. Biomarkers Prev. 5: 823-833.
8. Gann, P. H., J. Ma, E. Giovannucci, W. C. Willette, F. M. Sacks, C. H. Hennekens, and M. J. Stampfer. 1999. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 59: 1225-1230.
9. Rao, V. A., N. Fleshner, and S. Agarwal. 1999. Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: a case-control study. Nutr. Cancer 33: 159-164.
10. Chen, L., M. Stacewicz-Sapuntzakis, C. Duncan, R. Sharifi, L. Ghosh, R. B. van Breemen, D. Ashton, and P. E. Bowen. 2001. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J. Natl. Cancer Inst. 93: 1872-1879.
11. Kucuk, O., F. H. Sarkar, W. Sakr, Z. Djuric, M. N. Pollak, F. Khachik, Y. W. Li, M. Banerjee, D. Grignon, J. S. Bertram, J. D. Crissman, E. J. Pontes, and D. P. Wood. 2001. Phase II randomized clinical trial of lycopene supplementation before radical prostactectomy. Cancer Epidemiol. Biomarkers Prev. 10: 861-868.
12. Karas, M., H. Amir, D. Fishman, M. Danilenko, S. Segal, A. Nahum, A. Koifmann, Y. Giat, J. Levy, and Y. Sharoni. 2000. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr. Cancer. 36: 101-111.
13. Breinholt, V., S. T. Lauridsen, B. Daneshvar, and J. Jakobsen. 2000. Dose-response effects of lycopene on selected drug-metabolizing and antioxidant enzymes in the rat. Cancer Lett. 154: 201-210.
14. Stahl, W., J. von Laar, H-D. Martin, T. Emmerich, and H. Sies. 2000. Stimulation of gap junctional communication: comparison of acyclo-retinoic acid and lycopene. Arch. Biochem. Biophys. 373: 271-274.
15. Levy, J., E. Bosin, B. Feldman, Y. Giat, A. Miinster, M. Danilenko, and Y. Sharoni. 1995. Lycopene is a more potent inhibitor of human cancer cell proliferation than either α-carotene or β-carotene. Nutr. Cancer. 24: 257-266.
16. Novotny, J. A., L. A. Zech, H. C. Furr, S. R. Ducker, and A. J. Clifford. 1996. Mathematical modeling in nutrition: constructing a physiological compartmental model of the dynamics of β-carotene metabolism. Adv. Food Nutr. Res. 40: 25-54.
17. Holloway, D. E., M. Yang, G. Paganga, C. A. Rice-Evans, and P. M. Bramley. 2000. Isomerization of dietary lycopene during assimilation and transport in plasma. Free Radic. Res. 32: 93-102.
18. Garg, V., P. E. Bowen, and M. Stacewicz-Sapuntzakis. 1995. Serum lycopene response to daily intake of tomato oleoresin (Abstract). FASEB J 9: 458.
19. Reich, P., H. Shwachman, and J. M. Craig. 1960. Lycopenemia: a variant of carotenemia. N. Engl. J. Med. 262: 263-269.
20. Lee, R. D., and D. C. Nieman. 1996. Assessment of the hospitalized patient. In Nutritional Assessment. 2nd ed. Lee, R. D., and D. C. Nieman, editors. WCB/McGraw-Hill, Burr Ridge, IL. 309-310.
21. Stacewicz-Sapuntzakis, M., P. E. Bowen, J. W. Kikendall, and M. Burgess. 1987. Simultaneous determination of serum retinol and various carotenoids: their distribution in middle-aged men and women. J. Micronut. Anal. 3: 27-45.
22. Duewer, D. L., M. C. Kline, K. E. Sharpless, J. B. Thomas, M. Stacewicz-Sapuntzakis, and A. L. Sowell. 2000. NIST micronutrients measurement quality assurance program: characterizing individual participant measurement performance over time. Anal. Chem. 72: 3611-3619.
23. Furr, H. C., and R. M. Clark. 1997. Intestinal absorption and tissue distribution of carotenoids. J. Nutr. Biochem. 8: 364-377.
24. Parker, R. S. 1996. Absorption, metabolism and transport of carotenoids. FASEB J 10: 542-551.
25. Snyder, W. S., M. J. Cook, E. S. Nasset, L. R. Karhausen, G. P. Howells, and I. Tipton. 1975. Report of the task group on reference man. In International Commission on Radiological Protection No. 23. Pergamon Press, New York. 273-334.
26. Grundy, S. M., H. Y. Mok, L. Zech, D. Steinberg, and M. Berman. 1979. Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia. J. Clin. Invest. 63: 1274-1283.
27. Metropolitan Life Insurance Company Statistical Bulletin. 1959. November-December. 40.
28. Wastney, M. E., B. H. Patterson, O. A. Linares, P. C. Greif, and R. C. Boston. 1999. Investigating Biological Systems Using Modeling. Academic Press, San Diego, CA.
29. Cortner, J. A., P. M. Coates, N. A. Le, D. A. Cryer, M. C. Ragni, A. Faulkner, and T. Langer. 1987. Kinetics of chylomicron remnant clearance in normal and in hyperlipoprotenemic subjects. J. Lipid Res. 28: 195-206.
30. Langer, T., W. Strober, and R. I. Levy. 1972. The metabolism of low density lipoprotein in familial type II hyperlipoprotenemia. J. Clin. Invest. 51: 1528-1536.
31. Rhoades, R. A., and G. A. Tanner. 1995. Medical Physiology. Little, Brown and Company, Boston, MA.
32. Food and Nutrition Board, Institute of Medicine. 2002. Dietary Reference Intakes. National Academy Press, Washington, DC.
33. Romanchik, J. E., D. W. Morel, and E. H. Harrison. 1995. Distributions of carotenoids and α-tocopherol among lipoproteins do not change when human plasma is incubated in vitro. J. Nutr. 125: 2610-2617.
34. Rock, C. L., M. E. Swendseid, R. A. Jacob, and R. W. McKee. 1992. Plasma carotenoid levels in human subjects fed a low carotenoid diet. J. Nutr. 122: 96-100.
35. Stahl, W., and H. Sies. 1992. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J. Nutr. 122: 2161-2166.
36. Bowen, P. E., M. Garg, M. Stacewicz-Sapuntzakis, L. Yelton, and R. S. Schreiner. 1993. Variability of serum carotenoids in response to control diets. Ann. N. Y. Acad. Sci. 691: 241-243.
37. Johnson, E. J., J. Qin, N. I. Krinsky, and R. M. Russell. 1997. Ingestion by men of a combined dose of β-carotene and lycopene does not affect the absorption of β-carotene but improves that of lycopene. J. Nutr. 127: 1833-1837.
38. Hollander, D., and P. E. Ruble, Jr. 1978. β-carotene intestinal absorption: bile, fatty acid, pH, and flow rate effects on transport. Am. J. Physiol. 235: 58-66.
39. El-Gorab, M. I., B. A. Underwood, and J. D. Loerch. 1975. The roles of bile salts in the uptake of β-carotene and retinol by rat everted gut sacs. Biochim. Biophys. Acta. 401: 265-277.
40. During, A., M. M. Hussain, D. W. Morel, and E. H. Harrison. 2002. Carotenoid uptake and secretion by Caco-2 cells: β-carotene isomer selectivity and carotenoid interactions. J. Lipid Res. 43: 1086-1095.
41. Erdman, J. W., T. L. Bierer, and E. T. Gugger. 1993. Absorption and transport of carotenoids. Ann. N. Y. Acad. Sci. 691: 76-85.
42. Tabunoki, H., H. Sugiyama, Y. Tanaka, H. Fujii, Y. Banno, Z. E. Jouni, M. Kobayashi, R. Sato, H. Maekawa, and K. Tsuchida. 2002. Isolation, characterization, and cDNA sequence of carotenoid binding protein from silk gland of Bombyx mori larvae. J. Biol. Chem. 277: 32133-32140.
43. Rao, M. N., P. Ghosh, and M. R. Lakshman. 1997. Purification and partial characterization of cellular carotenoid-binding protein from ferret liver. J. Biol. Chem. 272: 24455-24460.
44. Brown, E. D., M. S. Micozzi, N. E. Craft, J. G. Bieri, G. R. Beecher, B. K. Edwards, A. Rose, P. R. Taylor, and J. C. Smith. 1989. Plasma carotenoids in normal men after a single ingestion of vegetables or purified β-carotene. Am. J. Clin. Nutr. 49: 1258-1265.
45. Kostic, D., W. S. White, and J. A. Olson. 1995. Intestinal absorption, serum clearance, and interactions between lutein and β-carotene when administered to human adults in separate or combined oral doses. Am. J. Clin. Nutr. 62: 604-610.
46. 13C tracer to quantify the plasma appearance of a physiological dose of lutein in humans. Lipids. 35: 339-348.
47. Bowen, P. E., S. M. Herbst-Espinosa, E. A. Hussain, and M. Stacewicz-Sapuntzakis. 2002. Esterification does not impair lutein bioavailability in humans. J. Nutr. 132: 3668-3673.
48. Giovannucci, E., E. B. Rimm, Y. Liu, M. J. Stampfer, and W. C. Willette. 2002. A prospective study of tomato products, lycopene, and prostate cancer risk. J. Natl. Cancer Inst. 94: 391-398.